STRING: 7955.ENSDARP00000022495
UniGene: Dr.76996
Recombinant Danio rerio lect1 is a protein produced through heterologous expression systems that corresponds to the native zebrafish chemotaxin. The protein is characterized by:
Alternative gene names: chm1, chmi
Post-translational processing resulting in multiple functional chains including Chondrosurfactant protein, CH-SP, and Chondromodulin-1
Expression hosts typically include E. Coli, Yeast, Baculovirus, or Mammalian Cell systems
Purification levels generally reach ≥85% purity as determined by SDS-PAGE analysis
For research applications, it is essential to verify whether you require the full-length protein or specific domains, as different recombinant constructs may represent partial or complete sequences depending on experimental goals.
The choice of expression system significantly impacts protein characteristics and downstream applications. Each system offers distinct advantages:
| Expression System | Advantages | Limitations | Recommended Applications |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid production | Limited post-translational modifications, potential inclusion bodies | Structural studies, antibody production, protein interaction assays |
| Yeast | Some post-translational modifications, higher yields than mammalian systems | Glycosylation patterns differ from vertebrates | Functional studies requiring basic modifications |
| Baculovirus | Complex eukaryotic processing, proper folding | Time-consuming, moderate yields | Enzymatic assays, receptor-binding studies |
| Mammalian Cell | Native-like post-translational modifications | Lower yields, higher cost, longer production time | In vivo applications, complex functional studies |
For studying chemotactic functions, mammalian or baculovirus systems are generally preferred as they better preserve the native protein conformation and post-translational modifications critical for biological activity .
To evaluate chemotactic function of recombinant lect1, researchers should implement a systematic approach:
Transwell Migration Assay: Similar to methods used for other chemotaxins like CXCL8, use a chamber with 3.0-μm-pore polycarbonate membrane inserts
Cell Preparation: Isolate target leukocytes from zebrafish (typically 1×10^6 cells/mL in appropriate media)
Concentration Gradient: Test protein at multiple concentrations (10-500 μg/mL) to establish dose-response relationship
Appropriate Controls:
Negative control: Phosphate-buffered saline
Blocking control: Antibody-blocked recombinant lect1
Positive control: Known chemotactic factor for the target cells
Quantification: Count migrated cells microscopically and calculate chemotactic index
Analysis should include statistical validation using appropriate tests such as ANOVA followed by multiple comparisons tests to determine significant differences between experimental conditions and controls .
A comprehensive validation strategy includes:
SDS-PAGE Analysis: Confirm ≥85% purity with appropriate molecular weight markers
Western Blot: Verify identity using specific antibodies against lect1 or epitope tags
Mass Spectrometry: Confirm protein sequence and identify post-translational modifications
Size Exclusion Chromatography: Assess aggregation state and homogeneity
Functional Validation: Perform chemotaxis assays with appropriate cell types
Endotoxin Testing: Ensure preparations are endotoxin-free (<0.1 EU/μg) for in vivo applications
Importantly, validation must include both structural and functional elements to ensure the recombinant protein represents the native lect1 activity .
Investigating the distinct functions of lect1 cleavage products requires:
Domain-specific Constructs: Generate recombinant proteins representing individual chains (Chondrosurfactant protein, CH-SP, Chondromodulin-1)
Site-directed Mutagenesis: Create cleavage-resistant variants by mutating processing sites
Domain-specific Antibodies: Develop tools that recognize individual domains for localization studies
Comparative Functional Assays: Assess chemotactic activity of individual domains versus the full-length protein
In vivo Domain Expression: Use transgenic zebrafish expressing individual domains under tissue-specific promoters
This approach enables mapping of function to structure and elucidates whether lect1 activity requires proteolytic processing or if individual domains possess independent biological activities .
To comprehensively analyze lect1 regulation during development:
Temporal Expression Analysis: Quantitative PCR at defined developmental stages (5-20 dpf)
Spatial Expression Mapping: In situ hybridization in embryos and tissue sections
Promoter Analysis: Identify regulatory elements using reporter constructs
Transcription Factor Identification:
ChIP-seq to identify protein-DNA interactions
EMSA to confirm specific binding
Reporter assays with mutated binding sites
Epigenetic Regulation: DNA methylation and histone modification analysis
Single-cell RNA-seq: Cell-type specific expression patterns during development
Integration of these approaches provides a multi-dimensional understanding of when, where, and how lect1 expression is regulated during zebrafish development .
Cross-species functional comparison requires systematic experimental design:
| Experimental Aspect | Methodological Approach | Key Considerations |
|---|---|---|
| Sequence Homology | Phylogenetic analysis, domain conservation mapping | Focus on functionally critical regions |
| Protein Structure | Comparative modeling, epitope mapping | Identify conserved structural motifs |
| Receptor Binding | Cross-species receptor activation assays | Test each protein on both zebrafish and mammalian receptors |
| Chemotactic Activity | Parallel migration assays with standardized conditions | Use both zebrafish and mammalian leukocytes |
| Gene Expression | Comparative transcriptomics under matched conditions | Analyze both constitutive and inducible expression |
| In vivo Function | Rescue experiments in knockout models | Test if mammalian LECT1 can rescue zebrafish lect1 deficiency |
This approach allows researchers to distinguish between conserved functions and species-specific adaptations .
To investigate evolutionary conservation of lect1 function:
Ortholog Identification: Comprehensive bioinformatic analysis across vertebrate species
Recombinant Protein Production: Express lect1 orthologs from multiple species (lamprey, zebrafish, chicken, mammals)
Standardized Functional Assays:
Chemotaxis assays using leukocytes from different species
Cross-species chemotactic activity testing
Structural Comparison: Identify conserved motifs (like the GGR motif found in lamprey CXCL8)
Receptor Conservation Analysis: Compare putative receptor binding domains
Induction Patterns: Compare expression responses to immune challenges across species
This approach allows researchers to trace the evolutionary history of chemotactic function from jawless vertebrates through teleost fish to mammals, providing insights into the origins of vertebrate immune chemotaxis .
When facing variability in chemotaxis experiments, systematically investigate:
Protein Quality Assessment:
Verify activity with positive control experiments
Check for protein degradation by SDS-PAGE
Ensure proper storage conditions (-80°C, avoid freeze-thaw cycles)
Experimental Variables Control:
Standardize cell isolation protocols
Maintain consistent temperature (18°C for fish cells)
Optimize incubation time (typically 4 hours)
Control for cell density (1×10^6 cells/mL)
Technical Refinements:
Establish optimal concentration range (typically peaks around 200 μg/mL)
Use blocking antibodies as specificity controls
Include multiple biological replicates
Standardize counting methods for migrated cells
Statistical Approach:
Apply appropriate statistical tests (Brown–Forsythe and Welch ANOVA)
Use multiple comparisons tests (Dunnett T3) for non-homogeneous variance
Report chemotactic index rather than absolute cell numbers
These systematic approaches minimize variability and enhance reproducibility in chemotaxis assays .
Rigorous immune response studies require comprehensive controls:
Negative Controls:
Vehicle treatment (PBS)
Unrelated recombinant protein of similar size
Heat-inactivated lect1
Positive Controls:
Known chemotactic factors like CXCL8
Species-appropriate immune stimulants
Specificity Controls:
Antibody-blocked lect1
Competitive inhibition with excess unlabeled protein
Receptor antagonists when available
Technical Controls:
Endotoxin testing of all preparations
Cell viability assessment before and after treatment
Time-course experiments to distinguish chemotaxis from chemokinesis
Biological Variables Control:
Age-matched animals
Same genetic background
Controlled environmental conditions
Sex-balanced experimental design when applicable
Implementing these controls ensures that observed effects are specifically attributable to lect1 function rather than experimental artifacts or contamination .
Effective CRISPR-Cas9 gene editing for lect1 functional studies requires:
Target Site Selection:
Design sgRNAs targeting early exons or critical functional domains
Avoid regions with high GC content or repetitive sequences
Evaluate potential off-target sites using prediction algorithms
Experimental Design:
Generate multiple independent mutant lines with different target sites
Create both knockout and knockin models (for domain-specific studies)
Consider conditional knockout approaches for developmental studies
Validation Strategy:
Sequence verification of mutations
RT-PCR and Western blot to confirm loss of expression
Structural protein analysis to confirm domain disruption
Phenotypic characterization at multiple developmental stages
Functional Rescue:
Complementation with wild-type lect1 mRNA
Domain-specific rescue to map function to structure
Cross-species rescue to assess functional conservation
This comprehensive approach enables precise dissection of lect1 function while minimizing misinterpretation due to off-target effects or compensatory mechanisms.
To comprehensively map lect1 protein interactions:
Affinity Purification-Mass Spectrometry:
Express tagged recombinant lect1
Perform pull-down experiments from zebrafish tissue lysates
Identify binding partners by mass spectrometry
Validate key interactions by co-immunoprecipitation
Yeast Two-Hybrid Screening:
Use lect1 domains as bait
Screen against zebrafish cDNA libraries
Confirm interactions in mammalian cells
Surface Plasmon Resonance:
Measure binding kinetics with purified candidate interactors
Determine domain-specific interactions
Compare with mammalian ortholog interactions
Proximity Labeling:
Express BioID or APEX2 fusion proteins in zebrafish
Capture transient and stable interactions in vivo
Analyze tissue and development-specific interactomes
Functional Validation:
Co-localization studies
Genetic interaction analysis using combined knockdowns
Competition assays to confirm specificity
This multi-method approach provides both physical and functional interaction data, creating a comprehensive map of lect1's biological network .
Translational applications of zebrafish lect1 research include:
Comparative Pathway Analysis:
Identify conserved signaling components between zebrafish and human
Map effects of lect1 modulation on downstream effectors
Determine potential off-target effects of therapeutic interventions
Drug Screening Platform:
Develop transgenic zebrafish reporters for lect1 activity
Screen compound libraries for modulators of lect1 function
Assess effects on development, inflammation, and immune response
Therapeutic Target Validation:
Use genetic models to confirm mechanism of action
Test antibody-based approaches for blocking specific domains
Evaluate peptide mimetics of functional domains
Safety Assessment:
Developmental toxicity screening
Long-term effects of pathway modulation
Effects on normal immune function and tissue homeostasis
This translational approach leverages the experimental advantages of zebrafish while generating data relevant to human therapeutic development .
To effectively study lect1 in inflammation and regeneration:
Inflammation Models:
Caudal fin amputation
Chemical-induced inflammation (LPS, copper sulfate)
Targeted tissue damage models (laser, genetic cell ablation)
Infection models with relevant pathogens
Regeneration Assessment:
Standardized morphometric analysis
Cell proliferation assays (BrdU, EdU incorporation)
Lineage tracing of regenerating tissues
Time-lapse imaging of reporter lines
lect1 Modulation Approaches:
Temporal control using heat-shock inducible transgenes
Tissue-specific knockdown/overexpression
Local delivery of recombinant protein
Small molecule modulators of lect1 signaling
Integrated Analysis:
Transcriptomics at defined regeneration stages
Immune cell infiltration assessment
Vascular response quantification
Extracellular matrix remodeling analysis